scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event
scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will participate in the 12th Annual LifeSci Partners Corporate Access Event on January 9-10, 2023, in San Francisco.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will participate in the 12th Annual LifeSci Partners Corporate Access Event on January 9-10, 2023, in San Francisco. The company focuses on developing products to optimize infused therapies, improve patient care, and reduce healthcare costs. Their key initiatives aim to facilitate outpatient treatment for acute conditions, particularly in heart failure and infectious diseases through subcutaneous self-administration of IV-strength therapies. More details regarding the event can be found on their website.
Details
News Market Reaction – SCPH
The recorded move for SCPH in the trading session of this news was -1.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to participate in the 12th Annual LifeSci Partners Corporate Access Event, on Monday, January 9 and Tuesday, January 10, 2023, in San Francisco. Learn more about the event and schedule an in-person meeting with the scPharmaceuticals management here.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com
Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.